Tirzepatide Alternatives in Vermont
Compare generic and therapeutic alternatives to Tirzepatide (tirzepatide) available at Vermont pharmacies. Save up to 38% on your prescription — no insurance required.
Top Alternatives in Vermont
Semaglutide (Ozempic/Wegovy)
therapeutic
GLP-1 agonist — well-established, slightly lower weight loss on average
Avg cash price: $940/mo
Compounded tirzepatide
therapeutic
Compounding pharmacy option — available during FDA shortage periods
Avg cash price: $300/mo
Rybelsus (oral semaglutide)
therapeutic
Oral daily tablet — no injection, moderate weight loss
Avg cash price: $870/mo
Vermont Prescription Assistance Programs
VPharm / VPharmAssist (Vermont Pharmaceutical Assistance)
State pharmaceutical assistance programs that historically helped eligible Vermont residents with prescription drug costs. Now largely superseded by Dr. Dynasaur and Green Mountain Care programs.
Eligibility: Contact the Vermont Agency of Human Services at 1-800-250-8427 for current program availability and eligibility thresholds.
Vermont Medicaid (Green Mountain Care)
Comprehensive prescription drug coverage through Vermont Medicaid for eligible residents.
Eligibility: Low-income Vermont adults, children, pregnant women, seniors, and people with disabilities. Vermont has very high Medicaid coverage rates.
Frequently Asked Questions
What is the difference between Mounjaro and Zepbound?
Mounjaro and Zepbound contain identical tirzepatide. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is FDA-approved for chronic weight management/obesity. Same drug, different labelled indication.
How much weight loss can I expect on tirzepatide?
The SURMOUNT trials showed average weight loss of 15–22.5% of body weight on tirzepatide 10–15 mg/week — greater than any other approved weight-loss medication and comparable to bariatric surgery outcomes.
How does tirzepatide differ from semaglutide?
Tirzepatide targets both GLP-1 and GIP receptors; semaglutide only targets GLP-1. The dual mechanism of tirzepatide produces greater average weight loss and HbA1c reduction in head-to-head trials (SURPASS-2).
Is there a cheaper alternative to tirzepatide?
Compounded tirzepatide from licensed pharmacies costs $250–$400/month during FDA shortage periods — 60–75% less than brand Mounjaro/Zepbound. Confirm current shortage status with your pharmacist.
Can Script Unlock help with tirzepatide costs?
Script Unlock connects patients with pharmacies carrying brand Mounjaro/Zepbound and compounding pharmacies offering tirzepatide during shortage periods. Post your prescription to compare bids.